Novartis has called off the sale of two US generics businesses to India’s Aurobindo Pharma, part of a restructuring of the Swiss big pharma as it concentrates more effort on higher-margin, innovative ...
An attempt by the British Generic Manufacturers Association (BGMA) to get a seat at the negotiation table for the new Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) has been knocked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results